AFAIK immunocore came out of same Oxford lab that spawned Adaptimmune. they had same scientific founder who used to have dual roles at both companies. but now he is only at immunocore. i took that to mean he thought adaptimmune needed less attention, on firmer footing etc.. i can't wait for a functional cure for HBV. I used to think enta was the lead on this, given its competency in HCV. but it seems no longer